Skip to main content
logo
PharmaCorp Rx Inc. (TSXV:PCRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.4700
-0.0050 (-1.05%)
Sep 3, 2026, 2:20 PM EST

PharmaCorp Rx Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
27.4120.895.79---
Revenue Growth
97.09%260.57%----
Gross Profit
10.838.32.18---
Operating Income
-1.31-1.24-1.59-0.58-0.56-0.08
Net Income
-1.07-1.48-1.01-0.47-0.52-0.08
Earnings Per Share
-0.01-0.01-0.01-0.02-0.03-
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025
Period EndingJun '26 Dec '25
Non-wholly Owned Pharmacies
9.936.24
Wholly Owned Pharmacies
17.4814.66
Total
27.4120.89

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
24.0125.8912.892.242.730.98
Total Debt
4.434.550.95---
Net Cash (Debt)
19.5921.3411.932.242.730.98
Net Cash Growth
125.53%78.82%432.33%-17.99%178.91%-
Net Cash Per Share
0.130.170.150.110.140.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
0.232.010.12-0.52-0.120
Capital Expenditures
-0.19-0.09-0.01---
Free Cash Flow
0.041.920.12-0.52-0.120
Free Cash Flow Growth
-87.66%1525.00%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.53%39.72%37.69%---
Operating Margin
-4.79%-5.92%-27.41%---
Pretax Margin
-2.81%-4.00%-19.97%---
Profit Margin
-3.89%-7.09%-17.48%---
FCF Margin
0.16%9.18%2.04%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
28.1444.00----
P/FCF Ratio
1905.0639.58536.42---
PS Ratio
2.993.6410.93---